Archive · 29 Dec 2025
Government Considers Extending Pharma Manufacturing Norms Deadline
The government is thinking about giving small pharmaceutical companies more time to follow new rules.
These companies say they can't make the necessary changes to their factories because they don't have enough space or can't change the layout.
The government is considering this request to help these small businesses.
The government is considering extending the deadline for implementing Revised Schedule M for pharmaceutical manufacturing.
MSMEs have expressed concerns about structural changes required for compliance.
Key issues include lack of space and inability to alter existing plant layouts.
The potential extension aims to support small firms facing physical constraints.
The government has received various representations from MSMEs regarding these challenges.
- Who
- Government and MSMEs in the pharmaceutical industry
- What
- Potential extension of the deadline for implementing new manufacturing practice norms (Revised Schedule M)
- When
- Not specified (ongoing consideration)
- Where
- India (implied by the context of MSMEs and government actions)
- Why
- To address concerns from MSMEs about structural changes and physical constraints in complying with the new norms
- Industry
- Pharmaceuticals
- Affected Entities
- MSMEs (Micro, Small, and Medium Enterprises)
- Main Concern
- Structural changes required under Revised Schedule M
- Constraints Mentioned
- Lack of space, inability to alter plant layouts
- Potential Action
- Extension of deadline for compliance
